MrgX2-Targeting Ligand Screen for Antipseudoallergic Agents by Immobilized His-Tag-Fused Protein Technology

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL Journal of Medicinal Chemistry Pub Date : 2025-03-04 DOI:10.1021/acs.jmedchem.5c00258
Zhaomin Xia, Qiumei Zhu, Yi Shan, Jiayu Lu, Meidi An, Xiaoxue Mo, Siqi Wang, Wen Yang, Hua Qian, Huaizhen He, Cheng Wang
{"title":"MrgX2-Targeting Ligand Screen for Antipseudoallergic Agents by Immobilized His-Tag-Fused Protein Technology","authors":"Zhaomin Xia, Qiumei Zhu, Yi Shan, Jiayu Lu, Meidi An, Xiaoxue Mo, Siqi Wang, Wen Yang, Hua Qian, Huaizhen He, Cheng Wang","doi":"10.1021/acs.jmedchem.5c00258","DOIUrl":null,"url":null,"abstract":"Mas-related G protein-coupled receptor X2 (MrgX2) plays a key role in pseudoallergy reactions; thus, it is of great significance to screen compounds with antipseudoallergy activity via MrgX2. Cell membrane chromatography (CMC) demonstrates great potential in drug screening, but it requires further optimization to improve its specificity and stability. In this study, a new CMC system incorporating His-tag-oriented immobilized proteins was constructed to screen MrgX2 antagonists. Single His-tag-fused MrgX2 was extracted intactly and covalently bond to divinyl sulfone-modified amino silica gel to obtain bioaffinity composites. The characterized composites were utilized to establish a MrgX2-His-tag@VS/CMC system to screen MrgX2 antagonists. Compound Z-3578 was screened from a G protein-coupled receptor compound library of 3010 compounds and revealed its efficient antipseudoallergy activity in vitro and in vivo via MrgX2. In conclusion, the new oriented-immobilized CMC system will provide an efficient analytical tool for screening active precursors.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"35 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.5c00258","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Mas-related G protein-coupled receptor X2 (MrgX2) plays a key role in pseudoallergy reactions; thus, it is of great significance to screen compounds with antipseudoallergy activity via MrgX2. Cell membrane chromatography (CMC) demonstrates great potential in drug screening, but it requires further optimization to improve its specificity and stability. In this study, a new CMC system incorporating His-tag-oriented immobilized proteins was constructed to screen MrgX2 antagonists. Single His-tag-fused MrgX2 was extracted intactly and covalently bond to divinyl sulfone-modified amino silica gel to obtain bioaffinity composites. The characterized composites were utilized to establish a MrgX2-His-tag@VS/CMC system to screen MrgX2 antagonists. Compound Z-3578 was screened from a G protein-coupled receptor compound library of 3010 compounds and revealed its efficient antipseudoallergy activity in vitro and in vivo via MrgX2. In conclusion, the new oriented-immobilized CMC system will provide an efficient analytical tool for screening active precursors.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
固定化his标签融合蛋白技术筛选mrgx2靶向配体抗假性过敏药物
mas相关G蛋白偶联受体X2 (MrgX2)在假过敏反应中起关键作用;因此,通过MrgX2筛选具有抗假过敏活性的化合物具有重要意义。细胞膜色谱法(CMC)在药物筛选中显示出巨大的潜力,但需要进一步优化以提高其特异性和稳定性。在本研究中,构建了一种新的CMC系统,结合his标签导向的固定化蛋白来筛选MrgX2拮抗剂。完整地提取单His-tag-fused MrgX2,并与二乙烯基砜修饰的氨基硅胶共价结合,得到生物亲和性复合材料。利用表征的复合材料建立MrgX2-His-tag@VS/CMC体系筛选MrgX2拮抗剂。从3010个G蛋白偶联受体化合物文库中筛选出化合物Z-3578,并通过MrgX2在体外和体内显示了其有效的抗假过敏活性。综上所述,新型定向固定化CMC系统将为活性前体筛选提供有效的分析工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
期刊最新文献
Piezo Family: From Structure to Therapeutic Agents in Cancer Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1-S-Checkpoint-Compromised Cancers. Development of a Dual Chemical Probe for the USP16 and HDAC6 Zinc-Finger Ubiquitin-Binding Domain Coibamide Analogue as a Novel-Class Payload for Antibody-Drug Conjugate Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1